Doba Parushev
Director of Corporate Venture Capital at Healthworx @ Healthworx
Washington, United States
Doba Parushev is a Series A investor at Healthworx in Washington focused on Health Care and Medical. Doba Parushev - Venture Capital @ CareFirst
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Doba Parushev invests in
Stages Doba Parushev invests in
Countries Doba Parushev invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 6 (60%)
- Medical 3 (30%)
- mHealth 2 (20%)
- Hospital 1 (10%)
- Wellness 1 (10%)
Stage
- Series A 5 (50%)
- Series B 2 (20%)
- Seed 1 (10%)
- Series D 1 (10%)
- Funding Round 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Culina Health is a personalized nutrition platform powered by registered dietitians to help you prioritize the way you want to live. We make insurance-covered nutrition care accessible and easier to understand so that you can fuel a satisfying and well balanced life. | $7.9M / Series A / Dec 19, 2024 | ||
| Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. Scene Health's 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivationalcontent, its bringd healthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Scene Health's mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. The company makes it fun for patients to stay on top of their medications, help them address any medication challenges, and empowers them to improve their health by identifying and addressing barriers to adherence related to social determinants of health. Over 120 customers across the healthcare landscape use our medication engagement program to improve medication adherence for patients with chronic and infectious diseases. | $17.7M / Series B / Apr 12, 2023 | ||
| Culina Health is a personalized nutrition platform powered by registered dietitians to help you prioritize the way you want to live. We make insurance-covered nutrition care accessible and easier to understand so that you can fuel a satisfying and well balanced life. | $4.8M / Seed / May 31, 2022 | ||
| Socially Determined identifies social risks and provides insights to prevent workplace social determinants of health (SDOH) with their software.Through Socialy Determined's software, theyr social risk intelligence platform informs the clients' organization's intervention strategies to identify the social risk drivers affecting theworkplace.Socially Determined was established on January 22, 2017 by Trenor Williams, and Ryan Bosch in Washington, DC. | $22.7M / Series B / May 31, 2022 | ||
| Getlabs is the leading platform for at-home diagnostics.Healthcare organizations use Getlabs to send mobile phlebotomists to patients’ homes and collect labs, vitals, and advanced diagnostics. By leveraging Getlabs, partners can improve patient adherence and close gaps in care with same-day, nationwide availability.Our team has raised $50M fromstrategic investors including the two largest diagnostic laboratories in the United States, Labcorp and Quest. Getlabs’ mission is to save lives by expanding access to diagnostics for everyone. | $20M / Series A / Feb 03, 2022 | ||
| ShiftMed offers a uniquely efficient and user-friendly approach to on-demand staffing for the healthcare industry with 90%+ show rates. | $45M / Series D / Oct 27, 2021 | ||
| Emocha enables every patient to take every dose of medication through video technology and scalable human engagement. Patients use a smartphone application to video record themselves taking their medication. Providers or emocha Adherence Coaches use a secure web portal to assess adherence and engage with patients. The platform is being used bypublic health departments, clinical trials, hospitals, health centers, and managed care organizations to radically improve medication adherence for patients with tuberculosis, opioid use disorder, hepatitis C, diabetes, and other chronic and infectious diseases. Emocha is available in more than 20 languages, works offline, and is asynchronous. It provides customizable reports to the care team and provider that provide a summary of adherence and other unique insights gleaned from daily video submissions. An NIH-funded study conducted by Johns Hopkins found that emocha helped patients achieve an average of 94 percent medication adherence. | $6.2M / Series A / May 18, 2021 | ||
| Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. Scene Health's 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivationalcontent, its bringd healthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Scene Health's mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. The company makes it fun for patients to stay on top of their medications, help them address any medication challenges, and empowers them to improve their health by identifying and addressing barriers to adherence related to social determinants of health. Over 120 customers across the healthcare landscape use our medication engagement program to improve medication adherence for patients with chronic and infectious diseases. | $6.2M / Series A / May 18, 2021 | ||
| Socially Determined identifies social risks and provides insights to prevent workplace social determinants of health (SDOH) with their software.Through Socialy Determined's software, theyr social risk intelligence platform informs the clients' organization's intervention strategies to identify the social risk drivers affecting theworkplace.Socially Determined was established on January 22, 2017 by Trenor Williams, and Ryan Bosch in Washington, DC. | $11.1M / Series A / Oct 28, 2019 | ||
| See all 10 investments → | |||
Co-Investors
Claritas Health Ventures
3 deals together
Kapor Capital
3 deals together
3TS Capital Partners
2 deals together
BIP Ventures
2 deals together
Blue Heron Capital
2 deals together
LRVHealth
2 deals together
About Healthworx
Healthworx operates at the intersection of healthcare and innovation by creating, supporting, and investing in companies that are improving healthcare quality, accessibility and affordability. As the innovation and investment arm of CareFirst of Maryland, Inc., Healthworx envisions a healthier future for all people by changing the way health works.
Healthworx Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Michael Batista
Director of Commercialization
|
|||
Soo Jeon
Co-Lead
|
|||
Dan Zohorsky
Managing Partner
|
|||
|
Doba Parushev
Director of Corporate Venture Capital at Healthworx
|
|||
Gerald Gallagher
Venture Capital Investor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Doba Parushev invest in?
Doba Parushev invests primarily in Health Care, Medical and mHealth startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Doba Parushev?
Public channels for Doba Parushev include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Doba Parushev last invest?
The most recent investment recorded for Doba Parushev closed in Dec 2024. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
